IGF2BP1 and neoplasm: In oral squamous cell carcinoma and seminoma cells, m6A/IGF2BP1-mediated mRNA stabilization of estrogen-related receptor alpha (ERRα) and transcription factor-activating enhancer-binding protein 2C (TFAP2C) can facilitate tumor cell survival upon cisplatin treatment.220